Non-obese | Obese | Morbidly Obese | p | |
---|---|---|---|---|
N | 39 | 17 | 34 | |
Sex (M/F) | 15/24 | 6/11 | 10/24 | 0.72 |
Body Mass Index (kg/m 2 ) | 25.4 ± 3.5 | 35.3 ± 3.1 | 46.1 ± 5.5 | < 0.0001 |
Age (years) | 46.7 ± 13.7 | 53.1 ± 14.9 | 43.1 ± 11 | 0.03 |
Glucose (mg/dl) | 93.8 ± 32.2 | 91.25 ± 11.8 | 124.8 ± 59.4 | 0.005 |
Cholesterol (mg/dl) | 195.5 ± 41.5 | 182.2 ± 34.8 | 189 ± 31.6 | 0.47 |
LDL-cholesterol (mg/dl) | 118 ± 35.8 | 99.6 ± 32.1 | 110.8 ± 36.7 | 0.27 |
HDL-cholesterol (mg/dl) | 57.2 ± 16.7 | 54.5 ± 16.9 | 59.15 ± 58.7 | 0.93 |
Log fasting tryglicerides | 1.98 ± 0.2 | 2.03 ± 0.2 | 2.11 ± 0.2 | 0.08 |
ACACA visceral (RU) | 0.04 ± 0.01 | 0.017 ± 0.003 | 0.02 ± 0.001 | 0.001 |
ACACA subcutaneous (RU)* | 0.033 ± 0.006 | 0.015 ± 0.002 | 0.02 ± 0.002 | 0.03 |
FASN visceral (RU) | 0.16 ± 0.02 | 0.07 ± 0.01 | 0.09 ± 0.01 | 0.02 |
FASN subcutaneous (RU)* | 0.36 ± 0.14 | 0.07 ± 0.02 | 0.06 ± 0.009 | 0.01 |
SREBP-1c visceral (RU) | 0.018 ± 0.002 | 0.013 ± 0.001 | 0.014 ± 0.001 | 0.2 |
SREBP-1c subcutaneous (RU)* | 0.019 ± 0.004 | 0.009 ± 0.001 | 0.009 ± 0.001 | 0.04 |
Spot-14 visceral (RU) | 0.26 ± 0.03 | 0.26 ± 0.03 | 0.23 ± 0.01 | 0.6 |
Spot-14 subcutaneous (RU)* | 0.60 ± 0.05 | 0.45 ± 0.003 | 0.48 ± 0.03 | 0.04 |
Caveolin visceral (RU) | 1.68 ± 0.9 | 1.04 ± 0.3 | 1.05 ± 0.3 | < 0.0001 |
Caveolin subcutaneous (RU)* | 1.50 ± 0.4 | 1.78 ± 0.8 | 1.44 ± 0.4 | 0.22 |